targeting therapies improve progression-free survival in melanoma
Published 3 years ago • 112 plays • Length 3:05Download video MP4
Download video MP3
Similar videos
-
1:46
targeted therapies for melanoma
-
1:09
progress in treatment approaches for patients with melanoma
-
4:08
survival improvements in melanoma
-
5:40
immunotherapy and targeted therapies for melanoma
-
1:58
progression free survival in advanced melanoma improved by cell therapy
-
2:03
immunotherapy before targeted therapy significantly improves advanced melanoma survival
-
2:40
neoadjuvant targeted therapy in braf v600 mutated melanoma
-
10:42
what is new in melanoma?
-
2:02
targeted therapies for melanoma treatment: a round-up of the important data presented at asco 2017
-
7:13
progression patterns in post-ipilimumab and anti-pd-1 in metastatic melanoma
-
1:25
targeting ras oncogenes in patients with nras-mutated melanoma
-
2:48
combining checkpoint blockade therapies in melanoma
-
4:18
development of novel treatments in melanoma patients with braf mutations
-
1:31
brim-3 trial in melanoma: prognostic factors of overall survival and the issue of salvage therapies
-
1:42
nibit-m2: 7-year outcomes and qol analysis in melanoma patients
-
5:34
developments in melanoma – new treatment options
-
4:05
vemurafenib and cobimetinib in patients with braf-mutated melanoma
-
3:35
keynote-006: the efficacy of ipilimumab after pembrolizumab in patients with advanced melanoma
-
3:25
is progression-free survival meaningful?